United States: FTC Merger Remedies Report Signals Tougher Enforcement

Last Updated: February 14 2017
Article by David P. Wales, J. Bruce McDonald and Ryan C. Thomas
Most Read Contributor in United States, September 2019

The Federal Trade Commission staff have completed a new study evaluating its process for designing and implementing merger remedies and the success of the remedies it has imposed in the past. Its report—"The FTC's Merger Remedies 2006-2012: A Report of the Bureaus of Competition and Economics"—follows a similar retrospective study from 1999 and also follows a number of recent matters where the agency's remedies were seen to have failed. Consistent with the experience of merging parties in recent years, the findings of this report confirm that the government will continue closely to scrutinize divestitures and other relief offered to remedy competition issues in transactions between companies with horizontal (at the same level of the supply chain) and vertical (at different levels) relationships. Although this report was issued by just one of the two federal antitrust agencies, and on the last day of the Obama Administration, the analysis and identified best practices are likely to resonate with the new leadership at both federal antitrust agencies, when they are appointed and take office.

The two federal agencies—the FTC and U.S. Antitrust Division of the Department of Justice—share jurisdiction to review mergers and acquisitions and to take enforcement action if a transaction is likely substantially to lessen competition in a U.S. market. In some (but not all) cases, it may be possible to prevent the harmful effects of the merger (and to preserve the deal efficiencies/synergies) without fully blocking the transaction. DOJ or FTC and the transaction parties may seek to design a structural (divestiture) or conduct (behavioral) "remedy" for the anticompetitive effects. In transactions that involve competitors, the agencies prefer structural relief in the form a divestiture of the assets of one of the parties in a line of business where the parties compete. Conduct relief may be required to supplement divestitures, or they may be imposed on a standalone basis to remedy alleged anticompetitive effects in a vertical merger; these include supply agreements, confidentiality protections, and employee obligations.

Both agencies have in recent years focused on designing better remedies, that is, remedies that are more likely to be successful in maintaining or restoring market competition following the merger. This effort, of course, translates into a greater burden on the merging parties, which must propose and implement remedies that satisfy the agencies' demands while avoiding expense or delay that undercuts the value of the original deal. If the agency and the parties cannot agree during the investigation phase on a remedy, their alternative is to litigate the lawfulness of the parties' proposed merger without a remedy or with the remedy proposed by the parties (known as "litigating the fix").

The Commission voted to authorize the report on January 19, 2017—the day before President Trump's inauguration—and the study was released in early February. Similar to the 1999 study, the current analysis is limited to FTC actions; DOJ did not participate in the current study, and so the report does not formally account for the efficacy and any lessons learned from transactions reviewed by DOJ.

In the recent study, FTC staff reviewed 89 remedies that were imposed between 2006 and 2012, gathering information on their effectiveness through interviews, questionnaires, and data requests directed at the merging parties, buyers of divested assets, and other market participants. Out of 50 cases in which staff conducted interviews and reviewed detailed sales data, they concluded that 80% of the studied remedies were "successful," which they defined as maintaining or restoring competition in the relevant market "within a short time." However, staff found some remedies to be less than successful, and identified improvements that could be made in its process. These suggest "best practices" in which the FTC will be more demanding of merging parties in the future. Even before the report was issued, there was evidence that both federal antitrust agencies were implementing some of these more rigorous standards, and the report likely will lead to even more demands on merging parties.

Implications of FTC study

The findings of the FTC study, including staff's observations on where they perceive past remedies have fallen short, provide useful guidance on what merging parties should expect in response to future remedy proposals:

Ongoing businesses. The clearest signal from the report is that the FTC will continue to prefer divestiture packages comprised of ongoing businesses as opposed to selected assets. The study found that, of the remedies investigated, all the divestitures of ongoing businesses were successful. By contrast, remedies of narrower packages of assets were only 70% successful, even where the remedy required an "up front buyer" that had been identified and committed to buy the assets before the main transaction was allowed to close. In recent years, both agencies have moved towards more often demanding divestitures of ongoing businesses; given the study results, merging companies should expect this increasingly to be the preference. The agencies may consider a package that includes assets that do not constitute an entire ongoing business, but will be more skeptical it will be successful and therefore more demanding of the parties to convince the agency the narrower package will work.

Buyers. Having identified that the success of a remedy often depends not just on the assets being divested but also on the strength of the buyer of the assets, going forward it should be expected that FTC will continue to review closely a buyer's financial strength, source of financing for the purchase, and track record of success in any prior acquisitions. FTC may also take steps to ensure the buyer can perform adequate due diligence on the assets it is purchasing and to encourage buyers to be forthcoming with their concerns if the asset package may be inadequate. And FTC will consider whether a proposed buyer has a "thoughtful" and credible business plan with realistic operational capabilities and financial wherewithal to compete in the near term and long term.

Support functions. Often the divested businesses or assets, having been part of a larger enterprise, relied on the enterprise's centralized backoffice functions, existing supply arrangements, or other support. FTC found that it sometimes was more difficult than expected for the new owner to transfer or replace these functions. This suggests that, going forward, FTC may seek longer and more well-defined transition agreements under which the merged company continues to support the business it has divested. As a practical matter, merging parties need to balance this interest against proposals that include "too many" ongoing entanglements between the merged company and its new competitor, the divestiture buyer. If a buyer requires significant backoffice and other support functions, and for an extended period of time (greater than 12-18 months), staff may question whether the buyer actually is capable of effectively operating the divested assets.

Although not detailed in the report, another important part of the agencies' evaluation of a proposed remedy is "market testing" the proposal in discussions with customers and other market participants to get a real world reaction. This is a critical step, as there almost always is some opportunity for the agency staff to find customers that oppose consolidation. This highlights the importance for the merging companies to consider their customers' likely reactions and to thoughtfully prepare a plan to communicate the procompetitive benefits of the deal.

Merging parties also should expect more oversight of this process, particularly for remedies involving complex industries and technical products (e.g., in the pharmaceutical and technology sectors), by independent monitors appointed by the agency to ensure successful transitions to the new owner.

Future remedy compliance

Within the FTC staff, preliminary approval of proposed remedies and oversight of a remedy's design and implementation is the responsibility of the Compliance Division of the Bureau of Competition, along with the staff that investigated the merger in the first place. The Compliance Division should be expected to take this new study as justification for continuing to ratchet upwards its insistence on detailed evidentiary support of proposed remedies.

Based on the findings of the FTC remedies study, it should be expected that FTC will continue to increase its remedy demands. Merging companies should anticipate:

  • Skepticism that a divestiture package that does not include the entire ongoing business should be accepted.
  • Requirement of better provisioning of backoffice functions, transition services, and supply agreements to support the divested business.
  • Close monitoring of the adequacy of due diligence made available to the proposed divestiture buyer.
  • Ensuring divestiture buyer access to customer and third party relationships.
  • Greater scrutiny of divestiture buyer financing and viability.
  • Increased use of up-front buyers.
  • Monitoring the overall divestiture process, including with an appointed "monitor trustee."
  • Encouragement that divestiture buyers reach out to FTC staff if they encounter difficulties.
  • Greater demands by the Compliance Division for information with which to evaluate the likely success of proposed remedies.
  • More delay in obtaining FTC approval of a divestiture package and proposed purchaser.

DOJ has no dedicated "Compliance" division or equivalent group whose focus is to help draft and negotiation remedies with merging parties. The DOJ staff that investigated the merger, along with their immediate supervisor (section chief), are responsible for negotiation of a potential remedy agreement. The proposed settlement is then vetted by DOJ management before being sent for final approval by the Assistant Attorney General for Antitrust. Although the DOJ did not participate in the FTC study, DOJ staff and the incoming leadership team are likely to consider similar best practices.

Although the report confirmed that the vast majority of remedies in FTC cases have been "successful," businesses and their counsel should focus on the remainder—the remedies that were deemed only a "qualified success" or a "failure," and the FTC staff's assessment of the reasons why. These cases, cautionary tales, are likely to drive the agencies' evaluations of all remedies; no staff lawyer or manager wants to be responsible for having signing off on a remedy that later proves flawed. Going forward, merging parties can expect enhanced scrutiny of proposed remedies at both agencies.

The full FTC study is available on the FTC's website.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions